Xprecia Prime™ is the new and improved generation of portable coagulation monitoring device. Xprecia Prime™ is small, accurate, and easy to use. This new coagulation analyzer is designed for fast and reliable PT/INR testing, allowing medical practitioners to monitor vitamin K antagonist oral anticoagulation therapy (e.g. Warfarin, Coumadin etc.) at the point of care (POC), primary care, urgent care, and hospitals. It should not be used to measure PT/INR in patients on other anticoagulation therapies. Xprecia Prime™ meets the modern high-quality POC coagulation testing requirements, providing PT/INR results comparable to laboratory analysis in under a minute.
Xprecia Prime™ is approved for sale in the USA through both a 510(k) and CLIA Waiver approval.
For Xprecia Prime™ and Xprecia Prime™ 4U for Australia: Investigational Use Only, With Approval Pending.
TGA application is pending clearance, Xprecia Prime™ and Xprecia Prime™ 4U is not for sale in Australia.
For Xprecia Prime™ for Singapore territory: Investigational Use Only, With Approval Pending.
Accuracy
Correlation of results with laboratory analysis
Reliable results, less repetition
Automatic strip quality check
Portability
Available anytime, anywhere
Ergonomic design – fits in the palm of a hand
Wi-Fi and wired connection
Rechargeable battery cell
Safety
Eject button for safe handling
PPID – Positive Patient Identification
Operator ID entry with lockout features
Simplicity
Results in less than one minute
User friendly software and touchscreen
Automatic calibration –
no reagents needed
Result in 5 simple steps, in under 1 minute